Pharmaceutical Intermediates and API Market Report

Europe Pharmaceutical Intermediates and API Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 13, 2019
  • PAGES：156
  • REPORT CODE：GMM316799
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Pharmaceutical Intermediates and API market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Pharmaceutical Intermediates and API Market Segmentations:

    By Player:

    • Tapi Teva

    • Cambrex Corporation

    • Menadiona

    • Esteve química S.A.

    • SUANFARMA

    • Duke Chem, S.A.

    • Duke Chem, SA

    • GSI Pharmaceuticals

    • GSK

    • Olon Spa

    • Esteve química SA

    • Interquim - Exquim, S.A.

    • Farmhispania

    • Derivados Químicos

    • Aurobindo

    • Sandoz

    • Inke, S.A.

    • ICROM

    • DISPROQUIMA, SA

    • DISPROQUIMA, S.A.

    • Inke, SA

    • Lonza

    • Uquifa

    • Centrient Pharmaceuticals

    • Lundbeck Pharmaceuticals

    • Ercros

    By Type:

    • Chiral Building Blocks

    • Achiral Building Blocks

    By End-User:

    • Pharmaceutical Companies

    • Research Labs

    • Contract Manufacturing Organizations

    • Other Industries

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pharmaceutical Intermediates and API Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Pharmaceutical Intermediates and API Market Size and Growth Rate of Chiral Building Blocks from 2014 to 2026

    • 1.3.2 Europe Pharmaceutical Intermediates and API Market Size and Growth Rate of Achiral Building Blocks from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Pharmaceutical Intermediates and API Market Size and Growth Rate of Pharmaceutical Companies from 2014 to 2026

    • 1.4.2 Europe Pharmaceutical Intermediates and API Market Size and Growth Rate of Research Labs from 2014 to 2026

    • 1.4.3 Europe Pharmaceutical Intermediates and API Market Size and Growth Rate of Contract Manufacturing Organizations from 2014 to 2026

    • 1.4.4 Europe Pharmaceutical Intermediates and API Market Size and Growth Rate of Other Industries from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pharmaceutical Intermediates and API Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pharmaceutical Intermediates and API by Major Types

      • 3.4.1 Market Size and Growth Rate of Chiral Building Blocks

      • 3.4.2 Market Size and Growth Rate of Achiral Building Blocks

    4 Segmentation of Pharmaceutical Intermediates and API Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pharmaceutical Intermediates and API by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pharmaceutical Intermediates and API for Pharmaceutical Companies

      • 4.4.2 Market Size and Growth Rate of Pharmaceutical Intermediates and API for Research Labs

      • 4.4.3 Market Size and Growth Rate of Pharmaceutical Intermediates and API for Contract Manufacturing Organizations

      • 4.4.4 Market Size and Growth Rate of Pharmaceutical Intermediates and API for Other Industries

    5 Market Analysis by Major Regions

    • 5.1 Europe Pharmaceutical Intermediates and API Production Analysis by Top Regions

    • 5.2 Europe Pharmaceutical Intermediates and API Consumption Analysis by Top Regions

    • 5.3 Europe Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

      • 5.3.3 France Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    6 Product Circulation of Pharmaceutical Intermediates and API Market among Top Countries

    • 6.1 Top 5 Export Countries in Pharmaceutical Intermediates and API Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Pharmaceutical Intermediates and API Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Pharmaceutical Intermediates and API Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Pharmaceutical Intermediates and API Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Pharmaceutical Intermediates and API Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Pharmaceutical Intermediates and API Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Pharmaceutical Intermediates and API Landscape Analysis

    • 7.1 Germany Pharmaceutical Intermediates and API Landscape Analysis by Major Types

    • 7.2 Germany Pharmaceutical Intermediates and API Landscape Analysis by Major End-Users

    8. UK Pharmaceutical Intermediates and API Landscape Analysis

    • 8.1 UK Pharmaceutical Intermediates and API Landscape Analysis by Major Types

    • 8.2 UK Pharmaceutical Intermediates and API Landscape Analysis by Major End-Users

    9. France Pharmaceutical Intermediates and API Landscape Analysis

    • 9.1 France Pharmaceutical Intermediates and API Landscape Analysis by Major Types

    • 9.2 France Pharmaceutical Intermediates and API Landscape Analysis by Major End-Users

    10. Italy Pharmaceutical Intermediates and API Landscape Analysis

    • 10.1 Italy Pharmaceutical Intermediates and API Landscape Analysis by Major Types

    • 10.2 Italy Pharmaceutical Intermediates and API Landscape Analysis by Major End-Users

    11. Spain Pharmaceutical Intermediates and API Landscape Analysis

    • 11.1 Spain Pharmaceutical Intermediates and API Landscape Analysis by Major Types

    • 11.2 Spain Pharmaceutical Intermediates and API Landscape Analysis by Major End-Users

    12. Poland Pharmaceutical Intermediates and API Landscape Analysis

    • 12.1 Poland Pharmaceutical Intermediates and API Landscape Analysis by Major Types

    • 12.2 Poland Pharmaceutical Intermediates and API Landscape Analysis by Major End-Users

    13. Russia Pharmaceutical Intermediates and API Landscape Analysis

    • 13.1 Russia Pharmaceutical Intermediates and API Landscape Analysis by Major Types

    • 13.2 Russia Pharmaceutical Intermediates and API Landscape Analysis by Major End-Users

    14. Switzerland Pharmaceutical Intermediates and API Landscape Analysis

    • 14.1 Switzerland Pharmaceutical Intermediates and API Landscape Analysis by Major Types

    • 14.2 Switzerland Pharmaceutical Intermediates and API Landscape Analysis by Major End-Users

    15. Turkey Pharmaceutical Intermediates and API Landscape Analysis

    • 15.1 Turkey Pharmaceutical Intermediates and API Landscape Analysis by Major Types

    • 15.2 Turkey Pharmaceutical Intermediates and API Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Landscape Analysis by Top Countries

      • 16.3.1 Denmark Pharmaceutical Intermediates and API Market Volume and Growth Rate

      • 16.3.2 Finland Pharmaceutical Intermediates and API Market Volume and Growth Rate

      • 16.3.3 Norway Pharmaceutical Intermediates and API Market Volume and Growth Rate

      • 16.3.4 Sweden Pharmaceutical Intermediates and API Market Volume and Growth Rate

      • 16.3.6 Iceland Pharmaceutical Intermediates and API Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Landscape Analysis by Top Countries

      • 17.3.1 Belgium Pharmaceutical Intermediates and API Market Volume and Growth Rate

      • 17.3.2 Netherlands Pharmaceutical Intermediates and API Market Volume and Growth Rate

      • 17.3.3 Luxembourg Pharmaceutical Intermediates and API Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Landscape Analysis by Top Countries

      • 18.3.1 Estonia Pharmaceutical Intermediates and API Market Volume and Growth Rate

      • 18.3.2 Latvia Pharmaceutical Intermediates and API Market Volume and Growth Rate

      • 18.3.3 Lithuania Pharmaceutical Intermediates and API Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Tapi Teva

      • 19.1.1 Tapi Teva Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Cambrex Corporation

      • 19.2.1 Cambrex Corporation Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Menadiona

      • 19.3.1 Menadiona Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Esteve química S.A.

      • 19.4.1 Esteve química S.A. Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 SUANFARMA

      • 19.5.1 SUANFARMA Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Duke Chem, S.A.

      • 19.6.1 Duke Chem, S.A. Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Duke Chem, SA

      • 19.7.1 Duke Chem, SA Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 GSI Pharmaceuticals

      • 19.8.1 GSI Pharmaceuticals Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 GSK

      • 19.9.1 GSK Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Olon Spa

      • 19.10.1 Olon Spa Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Esteve química SA

      • 19.11.1 Esteve química SA Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Interquim - Exquim, S.A.

      • 19.12.1 Interquim - Exquim, S.A. Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Farmhispania

      • 19.13.1 Farmhispania Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Derivados Químicos

      • 19.14.1 Derivados Químicos Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Aurobindo

      • 19.15.1 Aurobindo Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Sandoz

      • 19.16.1 Sandoz Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Inke, S.A.

      • 19.17.1 Inke, S.A. Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 ICROM

      • 19.18.1 ICROM Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 DISPROQUIMA, SA

      • 19.19.1 DISPROQUIMA, SA Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 DISPROQUIMA, S.A.

      • 19.20.1 DISPROQUIMA, S.A. Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Inke, SA

      • 19.21.1 Inke, SA Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Lonza

      • 19.22.1 Lonza Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Uquifa

      • 19.23.1 Uquifa Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Centrient Pharmaceuticals

      • 19.24.1 Centrient Pharmaceuticals Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    • 19.25 Lundbeck Pharmaceuticals

      • 19.25.1 Lundbeck Pharmaceuticals Company Profile and Development Status

      • 19.25.2 Market Performance

      • 19.25.3 Product and Service Introduction

    • 19.26 Ercros

      • 19.26.1 Ercros Company Profile and Development Status

      • 19.26.2 Market Performance

      • 19.26.3 Product and Service Introduction

    The List of Tables and Figures (Totals 109 Figures and 124 Tables)

    • Figure Product Picture

    • Figure Europe Pharmaceutical Intermediates and API Market Size and Growth Rate of Chiral Building Blocks from 2014 to 2026

    • Figure Europe Pharmaceutical Intermediates and API Market Size and Growth Rate of Achiral Building Blocks from 2014 to 2026

    • Figure Europe Pharmaceutical Intermediates and API Market Size and Growth Rate of Pharmaceutical Companies from 2014 to 2026

    • Figure Europe Pharmaceutical Intermediates and API Market Size and Growth Rate of Research Labs from 2014 to 2026

    • Figure Europe Pharmaceutical Intermediates and API Market Size and Growth Rate of Contract Manufacturing Organizations from 2014 to 2026

    • Figure Europe Pharmaceutical Intermediates and API Market Size and Growth Rate of Other Industries from 2014 to 2026

    • Figure Germany Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure UK Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure France Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Pharmaceutical Intermediates and API Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pharmaceutical Intermediates and API Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pharmaceutical Intermediates and API

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pharmaceutical Intermediates and API by Different Types from 2014 to 2026

    • Table Consumption Share of Pharmaceutical Intermediates and API by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Chiral Building Blocks

    • Figure Market Size and Growth Rate of Achiral Building Blocks

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pharmaceutical Intermediates and API by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pharmaceutical Intermediates and API by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Pharmaceutical Companies

    • Figure Market Size and Growth Rate of Research Labs

    • Figure Market Size and Growth Rate of Contract Manufacturing Organizations

    • Figure Market Size and Growth Rate of Other Industries

    • Table Europe Pharmaceutical Intermediates and API Production by Major Regions

    • Table Europe Pharmaceutical Intermediates and API Production Share by Major Regions

    • Figure Europe Pharmaceutical Intermediates and API Production Share by Major Countries and Regions in 2014

    • Table Europe Pharmaceutical Intermediates and API Consumption by Major Regions

    • Table Europe Pharmaceutical Intermediates and API Consumption Share by Major Regions

    • Table Germany Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    • Table UK Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    • Table France Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    • Table Italy Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    • Table Spain Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    • Table Poland Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    • Table Russia Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    • Table Switzerland Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    • Table Turkey Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Pharmaceutical Intermediates and API Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Pharmaceutical Intermediates and API Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Pharmaceutical Intermediates and API Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Pharmaceutical Intermediates and API Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Pharmaceutical Intermediates and API Consumption by Types from 2014 to 2026

    • Table Germany Pharmaceutical Intermediates and API Consumption Share by Types from 2014 to 2026

    • Table Germany Pharmaceutical Intermediates and API Consumption by End-Users from 2014 to 2026

    • Table Germany Pharmaceutical Intermediates and API Consumption Share by End-Users from 2014 to 2026

    • Table UK Pharmaceutical Intermediates and API Consumption by Types from 2014 to 2026

    • Table UK Pharmaceutical Intermediates and API Consumption Share by Types from 2014 to 2026

    • Table UK Pharmaceutical Intermediates and API Consumption by End-Users from 2014 to 2026

    • Table UK Pharmaceutical Intermediates and API Consumption Share by End-Users from 2014 to 2026

    • Table France Pharmaceutical Intermediates and API Consumption by Types from 2014 to 2026

    • Table France Pharmaceutical Intermediates and API Consumption Share by Types from 2014 to 2026

    • Table France Pharmaceutical Intermediates and API Consumption by End-Users from 2014 to 2026

    • Table France Pharmaceutical Intermediates and API Consumption Share by End-Users from 2014 to 2026

    • Table Italy Pharmaceutical Intermediates and API Consumption by Types from 2014 to 2026

    • Table Italy Pharmaceutical Intermediates and API Consumption Share by Types from 2014 to 2026

    • Table Italy Pharmaceutical Intermediates and API Consumption by End-Users from 2014 to 2026

    • Table Italy Pharmaceutical Intermediates and API Consumption Share by End-Users from 2014 to 2026

    • Table Spain Pharmaceutical Intermediates and API Consumption by Types from 2014 to 2026

    • Table Spain Pharmaceutical Intermediates and API Consumption Share by Types from 2014 to 2026

    • Table Spain Pharmaceutical Intermediates and API Consumption by End-Users from 2014 to 2026

    • Table Spain Pharmaceutical Intermediates and API Consumption Share by End-Users from 2014 to 2026

    • Table Poland Pharmaceutical Intermediates and API Consumption by Types from 2014 to 2026

    • Table Poland Pharmaceutical Intermediates and API Consumption Share by Types from 2014 to 2026

    • Table Poland Pharmaceutical Intermediates and API Consumption by End-Users from 2014 to 2026

    • Table Poland Pharmaceutical Intermediates and API Consumption Share by End-Users from 2014 to 2026

    • Table Russia Pharmaceutical Intermediates and API Consumption by Types from 2014 to 2026

    • Table Russia Pharmaceutical Intermediates and API Consumption Share by Types from 2014 to 2026

    • Table Russia Pharmaceutical Intermediates and API Consumption by End-Users from 2014 to 2026

    • Table Russia Pharmaceutical Intermediates and API Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Pharmaceutical Intermediates and API Consumption by Types from 2014 to 2026

    • Table Switzerland Pharmaceutical Intermediates and API Consumption Share by Types from 2014 to 2026

    • Table Switzerland Pharmaceutical Intermediates and API Consumption by End-Users from 2014 to 2026

    • Table Switzerland Pharmaceutical Intermediates and API Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Pharmaceutical Intermediates and API Consumption by Types from 2014 to 2026

    • Table Turkey Pharmaceutical Intermediates and API Consumption Share by Types from 2014 to 2026

    • Table Turkey Pharmaceutical Intermediates and API Consumption by End-Users from 2014 to 2026

    • Table Turkey Pharmaceutical Intermediates and API Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates and API Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Pharmaceutical Intermediates and API Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Pharmaceutical Intermediates and API Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Pharmaceutical Intermediates and API Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Pharmaceutical Intermediates and API Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Pharmaceutical Intermediates and API Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates and API Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Pharmaceutical Intermediates and API Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Pharmaceutical Intermediates and API Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pharmaceutical Intermediates and API Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates and API Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Pharmaceutical Intermediates and API Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Pharmaceutical Intermediates and API Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Pharmaceutical Intermediates and API Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Tapi Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tapi Teva

    • Figure Sales and Growth Rate Analysis of Tapi Teva

    • Figure Revenue and Market Share Analysis of Tapi Teva

    • Table Product and Service Introduction of Tapi Teva

    • Table Company Profile and Development Status of Cambrex Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cambrex Corporation

    • Figure Sales and Growth Rate Analysis of Cambrex Corporation

    • Figure Revenue and Market Share Analysis of Cambrex Corporation

    • Table Product and Service Introduction of Cambrex Corporation

    • Table Company Profile and Development Status of Menadiona

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Menadiona

    • Figure Sales and Growth Rate Analysis of Menadiona

    • Figure Revenue and Market Share Analysis of Menadiona

    • Table Product and Service Introduction of Menadiona

    • Table Company Profile and Development Status of Esteve química S.A.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Esteve química S.A.

    • Figure Sales and Growth Rate Analysis of Esteve química S.A.

    • Figure Revenue and Market Share Analysis of Esteve química S.A.

    • Table Product and Service Introduction of Esteve química S.A.

    • Table Company Profile and Development Status of SUANFARMA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SUANFARMA

    • Figure Sales and Growth Rate Analysis of SUANFARMA

    • Figure Revenue and Market Share Analysis of SUANFARMA

    • Table Product and Service Introduction of SUANFARMA

    • Table Company Profile and Development Status of Duke Chem, S.A.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Duke Chem, S.A.

    • Figure Sales and Growth Rate Analysis of Duke Chem, S.A.

    • Figure Revenue and Market Share Analysis of Duke Chem, S.A.

    • Table Product and Service Introduction of Duke Chem, S.A.

    • Table Company Profile and Development Status of Duke Chem, SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Duke Chem, SA

    • Figure Sales and Growth Rate Analysis of Duke Chem, SA

    • Figure Revenue and Market Share Analysis of Duke Chem, SA

    • Table Product and Service Introduction of Duke Chem, SA

    • Table Company Profile and Development Status of GSI Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSI Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of GSI Pharmaceuticals

    • Figure Revenue and Market Share Analysis of GSI Pharmaceuticals

    • Table Product and Service Introduction of GSI Pharmaceuticals

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Olon Spa

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Olon Spa

    • Figure Sales and Growth Rate Analysis of Olon Spa

    • Figure Revenue and Market Share Analysis of Olon Spa

    • Table Product and Service Introduction of Olon Spa

    • Table Company Profile and Development Status of Esteve química SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Esteve química SA

    • Figure Sales and Growth Rate Analysis of Esteve química SA

    • Figure Revenue and Market Share Analysis of Esteve química SA

    • Table Product and Service Introduction of Esteve química SA

    • Table Company Profile and Development Status of Interquim - Exquim, S.A.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Interquim - Exquim, S.A.

    • Figure Sales and Growth Rate Analysis of Interquim - Exquim, S.A.

    • Figure Revenue and Market Share Analysis of Interquim - Exquim, S.A.

    • Table Product and Service Introduction of Interquim - Exquim, S.A.

    • Table Company Profile and Development Status of Farmhispania

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Farmhispania

    • Figure Sales and Growth Rate Analysis of Farmhispania

    • Figure Revenue and Market Share Analysis of Farmhispania

    • Table Product and Service Introduction of Farmhispania

    • Table Company Profile and Development Status of Derivados Químicos

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Derivados Químicos

    • Figure Sales and Growth Rate Analysis of Derivados Químicos

    • Figure Revenue and Market Share Analysis of Derivados Químicos

    • Table Product and Service Introduction of Derivados Químicos

    • Table Company Profile and Development Status of Aurobindo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurobindo

    • Figure Sales and Growth Rate Analysis of Aurobindo

    • Figure Revenue and Market Share Analysis of Aurobindo

    • Table Product and Service Introduction of Aurobindo

    • Table Company Profile and Development Status of Sandoz

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz

    • Figure Sales and Growth Rate Analysis of Sandoz

    • Figure Revenue and Market Share Analysis of Sandoz

    • Table Product and Service Introduction of Sandoz

    • Table Company Profile and Development Status of Inke, S.A.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Inke, S.A.

    • Figure Sales and Growth Rate Analysis of Inke, S.A.

    • Figure Revenue and Market Share Analysis of Inke, S.A.

    • Table Product and Service Introduction of Inke, S.A.

    • Table Company Profile and Development Status of ICROM

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ICROM

    • Figure Sales and Growth Rate Analysis of ICROM

    • Figure Revenue and Market Share Analysis of ICROM

    • Table Product and Service Introduction of ICROM

    • Table Company Profile and Development Status of DISPROQUIMA, SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DISPROQUIMA, SA

    • Figure Sales and Growth Rate Analysis of DISPROQUIMA, SA

    • Figure Revenue and Market Share Analysis of DISPROQUIMA, SA

    • Table Product and Service Introduction of DISPROQUIMA, SA

    • Table Company Profile and Development Status of DISPROQUIMA, S.A.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DISPROQUIMA, S.A.

    • Figure Sales and Growth Rate Analysis of DISPROQUIMA, S.A.

    • Figure Revenue and Market Share Analysis of DISPROQUIMA, S.A.

    • Table Product and Service Introduction of DISPROQUIMA, S.A.

    • Table Company Profile and Development Status of Inke, SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Inke, SA

    • Figure Sales and Growth Rate Analysis of Inke, SA

    • Figure Revenue and Market Share Analysis of Inke, SA

    • Table Product and Service Introduction of Inke, SA

    • Table Company Profile and Development Status of Lonza

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lonza

    • Figure Sales and Growth Rate Analysis of Lonza

    • Figure Revenue and Market Share Analysis of Lonza

    • Table Product and Service Introduction of Lonza

    • Table Company Profile and Development Status of Uquifa

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Uquifa

    • Figure Sales and Growth Rate Analysis of Uquifa

    • Figure Revenue and Market Share Analysis of Uquifa

    • Table Product and Service Introduction of Uquifa

    • Table Company Profile and Development Status of Centrient Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Centrient Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Centrient Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Centrient Pharmaceuticals

    • Table Product and Service Introduction of Centrient Pharmaceuticals

    • Table Company Profile and Development Status of Lundbeck Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lundbeck Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Lundbeck Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Lundbeck Pharmaceuticals

    • Table Product and Service Introduction of Lundbeck Pharmaceuticals

    • Table Company Profile and Development Status of Ercros

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ercros

    • Figure Sales and Growth Rate Analysis of Ercros

    • Figure Revenue and Market Share Analysis of Ercros

    • Table Product and Service Introduction of Ercros

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US